SEC Form 4 · accession 0001104659-18-041289
Axsome Therapeutics, Inc. · AXSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Pizzie
Officer — Chief Financial Officer
Period of report
Jun 19, 2018
Accepted (ET)
Jun 20, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001579428
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 19, 2018 | P | 400 | $3.05 | A | 400 | D | |
| Common Stock | Jun 19, 2018 | P | 30,600 | $3.10 | A | 31,000 | D |
Table II — derivative securities
No Table II lines on this filing.